305 related articles for article (PubMed ID: 12149195)
21. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
[TBL] [Abstract][Full Text] [Related]
22. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
[TBL] [Abstract][Full Text] [Related]
23. Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Xu W; Li JY; Shen QD; Wu YJ; Yu H; Fan L
Int J Lab Hematol; 2009 Oct; 31(5):552-9. PubMed ID: 18616755
[TBL] [Abstract][Full Text] [Related]
24. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
[TBL] [Abstract][Full Text] [Related]
25. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
26. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
[TBL] [Abstract][Full Text] [Related]
27. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
[TBL] [Abstract][Full Text] [Related]
28. CD38 as a prognostic marker in CLL.
Matrai Z
Hematology; 2005 Feb; 10(1):39-46. PubMed ID: 16019444
[TBL] [Abstract][Full Text] [Related]
29. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
Hamblin TJ; Davis Z; Gardiner A; Oscier DG; Stevenson FK
Blood; 1999 Sep; 94(6):1848-54. PubMed ID: 10477713
[TBL] [Abstract][Full Text] [Related]
30. NOTCH1 mutations in CLL associated with trisomy 12.
Balatti V; Bottoni A; Palamarchuk A; Alder H; Rassenti LZ; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2012 Jan; 119(2):329-31. PubMed ID: 22086416
[TBL] [Abstract][Full Text] [Related]
31. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
32. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
[TBL] [Abstract][Full Text] [Related]
33. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.
Thornton PD; Fernandez C; Giustolisi GM; Morilla R; Atkinson S; A'Hern RP; Matutes E; Catovsky D
Hematol J; 2004; 5(2):145-51. PubMed ID: 15048065
[TBL] [Abstract][Full Text] [Related]
34. The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Dreger P; Stilgenbauer S; Benner A; Ritgen M; Kröber A; Kneba M; Schmitz N; Döhner H
Blood; 2004 Apr; 103(7):2850-8. PubMed ID: 14670929
[TBL] [Abstract][Full Text] [Related]
35. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
[TBL] [Abstract][Full Text] [Related]
36. [Research progress on prognostic markers of chronic lymphocytic leukemia].
Mao J; Mao ZR; Zhou R
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):250-6. PubMed ID: 20544986
[TBL] [Abstract][Full Text] [Related]
37. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
[TBL] [Abstract][Full Text] [Related]
39. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
[TBL] [Abstract][Full Text] [Related]
40. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]